StockWatch
·

BERYL DRUGS LTD. Q1 FY26 Results

BERLDRGQ1 FY26 Results
Filing
MetricValue ( Cr)vs Q4 FY25
Revenue4.7920.6%
Total Income4.847.3%
Expenditure4.776.9%
PBT0.0731.5%
Net Profit0.0286.1%
OPM10.64%29.48pp
NPM0.44%2.47pp
EPS0.0486.7%
View full financials

Informational and educational content only. Not investment advice.